UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35068 ACELRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 41-2193603 (State or other jurisdiction of inc ...

AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer Vincent Angotti - Chief Executive Officer & Director Pamela Palmer - Co-Founder, Chief Medical Officer & Director Conference Call Participants Michael Higgins - Ladenburg Evan Seigerman - Credit Suisse Operator Welcome to the AcelRx Third Quarter 2020 Conference Call. This call is being webcast live on the Events page of the Investors section of Acel ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORTS PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number: 001-35068 ACELRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 41-2193603 (State or other jurisdi ...

AcelRx Pharmaceuticals, Inc. (ACRX) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Raffi Asadorian - CFO Vincent Angotti - CEO & Director Pamela Palmer - Co-Founder, Chief Medical Officer & Director Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Michael Higgins - Ladenburg Thalmann & Co. Evan Seigerman - Crédit Suisse Operator Welcome to the Acelrx Second Quarter 2020 Conference Call. This call is being webcast live on the Events page of the Investors ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORTS PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number: 001-35068 ACELRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 41-2193603 (State or other jurisdiction ...

AcelRx Pharmaceuticals, Inc. (ACRX) Q1 2020 Results Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Raffi Asadorian - CFO Vince Angotti - CEO Pamela Palmer - Chief Medical Officer and Co-Founder Christian Tvetenstrand - Chairman of Surgery & Director of Trauma, Wilson Medical Center Conference Call Participants Brandon Folkes - Cantor Fitzgerald Thomas Yip - H.C. Wainwright Operator Welcome to the AcelRx's First Quarter 2020 Conference Call. This call is being webcast live on the event ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORTS PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission File Number: 001-35068 ACELRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware 41-2193603 (State or other jurisdictio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35068 ACELRX PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organi ...

AcelRx Pharmaceuticals, Inc. (ACRX) Q4 2019 Results Earnings Conference Call March 16, 2020 8:30 AM ET Company Participants Raffi Asadorian - CFO Vince Angotti - CEO Pamela Palmer - Chief Medical Officer and Co-Founder Koth Cassavaugh - Director of Pharmacy, Auburn Community Hospital Conference Call Participants Brandon Folkes - Cantor Fitzgerald Chris Howerton - Jefferies Ed Arce - H.C. Wainwright Michael Higgins - Ladenburg Thalmann Operator Good day, and welcome to the AcelRx's Fiyrtg Quarter 2019 and Te ...

AcelRx Pharmaceuticals, Inc. (ACRX) Q3 2019 Earnings Conference Call November 6, 2019 5:00 PM ET Company Participants Raffi Asadorian - CFO Vince Angotti - CEO Pam Palmer - Chief Medical Officer and Co-Founder Charles Lee - Board Certified Plastic and Reconstructive Surgeon Conference Call Participants Ed Arce - H.C. Wainwright Syed Kareem - Jefferies Michael Higgins - Ladenburg Thalmann Operator Good day, and welcome to the AcelRx's Third Quarter 2019 Conference Call. This call is being webcast live on the ...